The present invention relates to cosmetic or pharmaceutical topical compositions containing at least one cyclic nucleotide having its 2′ hydroxyl group replaced by a hydrogen atom for inhibiting phosphodiesterase activity. The phosphodiesterase inhibitor is in combination with a magnesium buffer and a cosmetically or pharmaceutically acceptable carrier. The invention also includes methods for treating or preventing inflammation or irritation such as is common in the skin disease, atopic dermatitis, which is known to be related to the uncontrolled activity of phosphodiesterase.
本发明涉及化妆品或药物外用组合物,其中至少含有一种环状核苷酸,其 2′羟基被氢原子取代,用于抑制
磷酸二酯酶活性。
磷酸二酯酶抑制剂与
镁缓冲剂和化妆品或药学上可接受的载体结合使用。本发明还包括治疗或预防炎症或刺激的方法,如皮肤病特应性皮炎中常见的炎症或刺激,众所周知,特应性皮炎与
磷酸二酯酶不受控制的活性有关。